drugset / Trial / NCT04080375

Preoperative Vaginal Dinoprostone Prior to Abdominal Myomectomy

NCT04080375

Phase 3 Unknown 100 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aim of the study is to compare the effectiveness of vaginal dinoprostone 3 mg versus placebo before myomectomy to decrease blood loss during and after the operation.

Timeline

Start
2019-09-10
Primary completion
2019-11-30
Completion
2019-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Dinoprostone Other / unclassified 3 mg Other

Indications